Skip to main content
TipRanks
Go Ultimate75% OFF

William Marth Insider Profile

4 Followers

William Marth, Director at Sorrento Therapeutics, holds 0.00 shares in Sorrento Therapeutics (Ticker: SRNE), holds 510.18K shares in Albany Molecular Research (Ticker: AMRI), holds ― shares in Teligent (Ticker: TLGTQ).

William Marth's Trading History

AMRI
Albany Molecular Research
Sep 05, 2017―Uninformative Sell10.51M$11.09M
TLGTQ
Teligent
――――
SRNE
Sorrento Therapeutics
―Director――

You May Also Like

William Marth insider profile FAQ

What is the percentage of profitable transactions made by William Marth?
The percentage of profitable transactions made by William Marth is 50%.
What is the average return per transaction made by William Marth?
The average return per transaction made by William Marth is 4.20%.
What stocks does William Marth hold?
William Marth holds: SRNE, AMRI, TLGTQ stocks.
What was William Marth's most profitable transaction?
William Marth’s most profitable transaction was an Informative Buy of AMRI stock on May 16, 2016. The return on the trade was 38.60%.
What is William Marth's role in Sorrento Therapeutics?
William Marth's role in Sorrento Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.